Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

The irbesartan reference standard calibration experiment establishes a certified, metrologically traceable purity value for irbesartan, an angiotensin II receptor antagonist widely used in antihypertensive drug products, by combining HPLC chromatographic purity, Karl Fischer water determination, residual solvent analysis, and orthogonal structural confirmation. This technical article details the complete calibration workflow, from candidate material qualification and homogeneity testing to potency calculation and measurement uncertainty evaluation, in accordance with ISO 17034, ISO/IEC 17025, ISO Guide 35, and the GB/T 15000 series for reference materials. Quality-control, method-development, and regulatory-affairs laboratories will find practical guidance on assigning, documenting, and periodically re-certifying irbesartan reference standards used in pharmaceutical assay and stability testing.

Technical Overview

Irbesartan (CAS 138402-11-6), with the molecular formula C25H28N6O and a molecular weight of 428.53 g/mol, is a white to off-white crystalline powder that acts as a selective angiotensin II type 1 (AT1) receptor antagonist. Because quantitative release testing of irbesartan drug substances and drug products depends entirely on the accuracy of the reference standard, the calibration experiment is designed to assign a defensible, traceable mass-fraction purity value to the standard before it is released for routine laboratory use.

The core of the calibration is the mass balance approach, in which the chromatographically determined purity is corrected for non-chromatographic contributions. The potency, expressed on an as-is basis, is calculated as: P(as-is) = P(HPLC) x [1 - w(water) - w(residual solvents) - w(inorganic residue)], where P(HPLC) is the HPLC area-normalization purity and the w terms are the mass fractions of water, residual solvents, and sulfated ash respectively. This approach ensures that every impurity class is accounted for exactly once, avoiding double counting and systematic bias.

All calibration activities are performed under a quality system conforming to ISO/IEC 17025 and ISO 17034, with reference material production, homogeneity assessment, stability monitoring, and uncertainty evaluation planned in line with ISO Guide 35 and the GB/T 15000 series. The certified value is traceable to the International System of Units (SI) through calibrated balances, validated chromatographic systems, and certified secondary standards used in orthogonal confirmation.

Testing Samples

Candidate Primary Reference Material

The candidate material is typically a highly purified irbesartan batch obtained from a qualified synthesis route followed by repeated recrystallization. Candidate lots should target at least 99.5% chromatographic purity with individual related substances below 0.05%. Between 1 g and 5 g of material is dispensed into individual amber glass vials under dry nitrogen, with each vial assigned a unique identification number for homogeneity and stability tracking.

Working Standard Batches

Working standards are qualified technical-grade or pharmacopoeial-grade irbesartan lots calibrated directly against the primary standard using a validated comparative HPLC assay. They are intended for routine batch release and in-process control, reserving the primary standard for calibration and dispute resolution. Each working standard must carry a certificate stating potency, uncertainty, expiry, and storage conditions.

Packaging, Storage, and Handling

Reference vials are sealed with PTFE-lined caps, protected from light and moisture, and stored in a desiccator at controlled room temperature or at 2 to 8 degrees Celsius depending on stability data. Before use, vials must be equilibrated to room temperature before opening to prevent condensation, and material should be used promptly after removal to minimize moisture uptake.

Testing Items

The calibration experiment comprises the following test items, each with predefined acceptance criteria:

  • Appearance and physical form verification against the specification.
  • Structural identity confirmation by 1H-NMR, 13C-NMR, FTIR, LC-MS, UV spectrophotometry, and melting point or DSC thermal behavior.
  • Chromatographic purity and related substances profile by HPLC-UV.
  • Water content by volumetric or coulometric Karl Fischer titration.
  • Residual solvents by headspace gas chromatography with FID detection.
  • Inorganic impurities by sulfated ash or residue on ignition.
  • Orthogonal absolute purity determination by quantitative 1H-NMR (qNMR).
  • Between-vial homogeneity testing by replicate HPLC assay under repeatability conditions.
  • Long-term and accelerated stability monitoring.
  • Potency assignment on an as-is and anhydrous basis, including expanded measurement uncertainty at approximately 95% confidence (k = 2).

Testing Methods

Structural Identification

1H and 13C-NMR spectra are acquired in DMSO-d6 at 400 MHz or higher and compared with the theoretical assignments and published spectral data. FTIR spectra must match reference spectra in the fingerprint region, and LC-MS must confirm the protonated molecular ion at m/z 429.3. Differential scanning calorimetry provides a sharp single melting endotherm, corroborating chemical identity and indicating high crystalline purity.

HPLC Chromatographic Purity

A stability-indicating reversed-phase method is used, typically employing a C18 column (250 mm x 4.6 mm, 5 micrometers), a mobile phase of phosphate buffer adjusted to pH approximately 3.0 with phosphoric acid and acetonitrile in gradient mode, a flow rate of about 1.0 mL/min, UV detection at 220 to 245 nm, and a column temperature of 30 degrees Celsius. System suitability requires resolution, tailing factor, and replicate injection RSD within predefined limits. Purity is calculated by area normalization corrected for response factors where known impurities are available, and the method must demonstrate sufficient sensitivity to quantify impurities at the 0.05% level.

Water Content Determination

Water is determined by volumetric Karl Fischer titration using approximately 30 to 50 mg of sample in anhydrous methanol as solvent, with six replicate determinations. Coulometric KF may be used when the expected water content is below 0.5%. The mean value and its uncertainty enter the mass balance equation directly.

Residual Solvent Analysis

Residual solvents such as acetonitrile, ethanol, ethyl acetate, and N,N-dimethylformamide are quantified by static headspace GC-FID against certified solvent standards. Results are compared with the impurity-reporting logic of the mass balance scheme: solvents detected above the quantitation limit are subtracted, while non-detects are treated as zero with an uncertainty allowance based on the quantitation limit.

Residue on Ignition

An accurately weighed sample of 1.0 g is charred, moistened with sulfuric acid, and ignited at 600 plus or minus 50 degrees Celsius to constant mass. The residue reflects inorganic impurities and is subtracted in the mass balance; a residue below the quantitation limit is assigned an uncertainty contribution rather than a numeric subtraction.

Orthogonal Verification by qNMR

To guard against method bias, the purity obtained by mass balance is cross-checked by quantitative 1H-NMR using a certified internal standard such as dimethyl sulfone or 1,4-bis(trimethylsilyl)benzene-d4 in DMSO-d6. A relaxation delay of at least five times the longest T1 is applied, and a minimum of six independent weighings are integrated. Agreement between qNMR and mass balance results within the combined uncertainty confirms the assigned value.

Mass Balance Calculation and Potency Assignment

In a representative calibration, an HPLC purity of 99.72%, water content of 0.21%, residual solvents of 0.03%, and sulfated ash below the quantitation limit yield a potency of 99.72 x (1 - 0.0021 - 0.0003) = 99.48% on an as-is basis. The potency, its uncertainty, the analytical raw data, and the metrological traceability chain are documented in the calibration report and certificate of analysis.

Homogeneity Testing

A minimum of ten randomly selected vials are analyzed in duplicate by HPLC under repeatability conditions. Between-vial and within-vial variances are evaluated by one-way analysis of variance, and the homogeneity uncertainty component is derived from the between-vial standard deviation. Homogeneity is considered acceptable when this component is insignificant relative to the combined uncertainty of the certified value.

Stability Assessment and Re-Certification

Long-term stability is monitored under the assigned storage condition, supported by accelerated storage at elevated temperature to model degradation pathways such as hydrolysis of the tetrazole-containing biphenyl system. A classical stability design per ISO Guide 35 establishes the shelf life, and a post-certification monitoring plan at defined intervals confirms continued validity of the certified value until the stated expiry.

Uncertainty Evaluation

The uncertainty budget combines contributions from HPLC purity determination, Karl Fischer water content, residual solvent analysis, sulfated ash, homogeneity, and long-term stability. The expanded uncertainty is reported as U = k x u(c) with a coverage factor k = 2, corresponding to approximately 95% confidence, and typically falls in the range of 0.2% to 0.4% relative for a well-characterized irbesartan standard.

Applications

Calibrated irbesartan reference standards underpin quantitative analysis throughout the pharmaceutical lifecycle:

  • Assay and related-substance release testing of irbesartan active pharmaceutical ingredients.
  • Content determination of immediate-release tablets and fixed-dose combination products containing irbesartan and hydrochlorothiazide.
  • Quantitative endpoints in dissolution profile testing and in-vitro equivalence studies.
  • Method validation, method transfer, and daily system suitability checks in quality-control laboratories.
  • Stability-indicating assays supporting shelf-life assignment in ICH-aligned stability programs.
  • Preparation of calibration standards for bioanalytical methods used in bioavailability and bioequivalence studies.
  • Proficiency testing schemes and interlaboratory comparisons organized by accredited third-party laboratories.
  • Incoming material inspection and supplier qualification programs for pharmaceutical manufacturers.

FAQ

What is the difference between a primary reference standard and a working standard for irbesartan?

A primary reference standard is the highest-purity material characterized by the full mass balance calibration described above and is reserved for calibrating working standards and resolving disputes. A working standard is a qualified lot whose potency is assigned by comparative assay against the primary standard and is used for routine batch testing to conserve the primary material.

Why is the mass balance approach preferred over direct titration?

Irbesartan lacks a sufficiently sharp, specific titrimetric endpoint, and titration cannot distinguish structurally related synthetic impurities. The mass balance approach couples the selectivity of HPLC with corrections for water, solvents, and inorganic residue, providing a transparent and metrologically defensible purity value.

What acceptance criteria are typically applied during calibration?

Common criteria include chromatographic purity of at least 99.5%, total related substances not more than 0.5%, individual impurities not more than 0.05%, water content not more than 0.5%, residual solvents within ICH Q3C limits, sulfated ash not more than 0.1%, and agreement between qNMR and mass balance within combined uncertainty.

How often should an irbesartan reference standard be re-certified?

Primary standards are typically assigned a validity period of 24 to 36 months supported by real-time stability data, with periodic verification at defined checkpoints. Working standards are re-qualified against the primary standard before expiry or whenever trending data, appearance changes, or storage excursions indicate potential degradation.

Can qNMR replace the HPLC-based calibration?

qNMR is a powerful orthogonal absolute method but has higher detection limits for minor impurities than HPLC-UV. Best practice is to use both in combination: HPLC quantifies trace organic impurities with high sensitivity, while qNMR independently confirms the absolute purity and detects potential HPLC response-factor bias.

How should the standard be stored and handled in daily use?

Store the vial sealed in a desiccator, protected from light, at the temperature stated on the certificate, and allow it to equilibrate to ambient temperature before opening. Record the dispensing history, avoid repeated freeze-thaw or humidity cycling, and never return unused material to the original vial.